Melola Discovery

← Melola Discovery

Akses terbuka Jurnal SINTA 1

Predicting active compounds for lung cancer based on quantitative structure-activity relationships

International Journal of Electrical and Computer Engineering (IJECE) · Vol. 13 No. 5 (2023)

DOI
10.11591/ijece.v13i5.pp5755-5763
ISSN
2722-2578, 2088-8708
Terbit
2023-10-01
Penerbit
Institute of Advanced Engineering and Science
Lisensi
creativecommons.org/licenses/by-sa/4.0

Abstrak

Recently, advancements in computational and artificial intelligence (AI) methods have contributed in improving research results in the field of drug discovery. In fact, machine learning techniques have proven to be especially effective in this regard, aiding in the development of new drug variants and enabling more precise targeting of specific disease mechanisms. In this paper, we propose to use a quantitative structure-activity relationship-based approach for predicting active compounds related to non-small cell lung cancer. Our approach uses a neural network classifier that learns from sequential structures and chemical properties of molecules, as well as a gradient boosting tree classifier to conduct comparative analysis. To evaluate the contribution of each feature, we employ Shapley additive explanations (SHAP) summary plots to perform features selection. Our approach involves a dataset of active and non-active molecules collected from ChEMBL database. Our results show the effectiveness of the proposed approach when it comes to predicting accurately active compounds for lung cancer. Furthermore, our comparative analysis reveals important chemical structures that contribute to the effectiveness of the compounds. Thus, the proposed approach can greatly enhance the drug discovery pipeline and may lead to the development of new and effective treatments for lung cancer.

Jaringan kolaborasi para penulis

6 penulis · 7 tautan kepenulisan bersama · 1 lintas organisasi

Arahkan kursor atau ketuk sebuah nama untuk menyorot rekan penulisnya. Klik dua kali untuk membuka halaman penulis.

  • Abdelmalek Essaâdi University
  • Sidi Mohamed Ben Abdellah University
  • Organisasi berbeda
  • Organisasi sama
  • Afiliasi tidak diketahui
  • Garis lebih tebal = lebih banyak artikel bersama · lingkaran lebih besar = lebih banyak artikel
Tampilkan sebagai tabel
Rekan penulisOrganisasiArtikel bersama
Mohamed Taj BennaniSidi Mohamed Ben Abdellah University1
Sara AhsainAbdelmalek Essaâdi University1
Yasyn ElyusufiAbdelmalek Essaâdi University1

Afiliasi berasal dari OpenAlex; metadata OAI-PMH jurnal tidak memuatnya. Penulis tanpa ID OpenAlex dicocokkan berdasarkan nama, sehingga dua orang bisa tergabung atau satu orang bisa terpisah.

Data ini berasal dari Crossref (yang disetorkan penerbit), karena endpoint OAI-PMH milik jurnal tidak dapat di-harvest.

Sumber metadata: Crossref API (cadangan, berdasarkan ISSN) https://api.crossref.org/journals/2088-8708/works, pertama di-harvest 27 Okt 2026, terakhir terlihat 15 Nov 2026.
Metadata sebagai oai_dc, dikonversi dari Crossref
<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"><dc:title>Predicting active compounds for lung cancer based on quantitative structure-activity relationships</dc:title><dc:creator>Hanafi, Hamza</dc:creator><dc:creator>Rossi Hassani, Badr Dine</dc:creator><dc:creator>Aït Kbir, M’hamed</dc:creator><dc:description>&lt;jats:p&gt;&amp;lt;span lang="EN-US"&amp;gt;Recently, advancements in computational and artificial intelligence (AI) methods have contributed in improving research results in the field of drug discovery. In fact, machine learning techniques have proven to be especially effective in this regard, aiding in the development of new drug variants and enabling more precise targeting of specific disease mechanisms. In this paper, we propose to use a quantitative structure-activity relationship-based approach for predicting active compounds related to non-small cell lung cancer. Our approach uses a neural network classifier that learns from sequential structures and chemical properties of molecules, as well as a gradient boosting tree classifier to conduct comparative analysis. To evaluate the contribution of each feature, we employ Shapley additive explanations (SHAP) summary plots to perform features selection. Our approach involves a dataset of active and non-active molecules collected from ChEMBL database. Our results show the effectiveness of the proposed approach when it comes to predicting accurately active compounds for lung cancer. Furthermore, our comparative analysis reveals important chemical structures that contribute to the effectiveness of the compounds. Thus, the proposed approach can greatly enhance the drug discovery pipeline and may lead to the development of new and effective treatments for lung cancer.&amp;lt;/span&amp;gt;&lt;/jats:p&gt;</dc:description><dc:publisher>Institute of Advanced Engineering and Science</dc:publisher><dc:date>2023-10-01</dc:date><dc:type>info:eu-repo/semantics/article</dc:type><dc:format>application/pdf</dc:format><dc:identifier>https://doi.org/10.11591/ijece.v13i5.pp5755-5763</dc:identifier><dc:identifier>10.11591/ijece.v13i5.pp5755-5763</dc:identifier><dc:source>International Journal of Electrical and Computer Engineering (IJECE); Vol 13 No 5 (2023); 5755</dc:source><dc:source>2722-2578</dc:source><dc:source>2088-8708</dc:source><dc:relation>https://ijece.iaescore.com/index.php/IJECE/article/viewFile/31562/16872</dc:relation><dc:rights>http://creativecommons.org/licenses/by-sa/4.0</dc:rights></oai_dc:dc>